Population pharmacokinetics of a posaconazole tablet formulation in transplant adult allogeneic stem cell recipients-Reference-Cited by-同舟云学术

Population pharmacokinetics of a posaconazole tablet formulation in transplant adult allogeneic stem cell recipients

Published:2022-01 Issue: Volume:168 Page:106049
ISSN:0928-0987
Container-title:European Journal of Pharmaceutical Sciences
language:en
Short-container-title:European Journal of Pharmaceutical Sciences

Author:

Peña-Lorenzo Diego,Rebollo Noemí,Sánchez-Hernández José Germán,Zarzuelo-Castañeda Aránzazu,Vázquez-López Lourdes,Otero María José,Pérez-Blanco Jonás Samuel

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference43 articles.

1. Therapeutic drug monitoring (TDM) of antifungal agents: guidelines from the British Society for Medical Mycology;Ashbee;J. Antimicrob. Chemother.,2014

2. NONMEM 7.1.0 Users Guides (1989-2009);Beal,2009

3. Clinical Pharmacokinetics and Dose Recommendations for Posaconazole in Infants and Children;Boonsathorn;Clin. Pharmacokinet.,2019

4. A post-marketing evaluation of posaconazole plasma concentrations in neutropenic patients with haematological malignancy receiving posaconazole prophylaxis;Bryant;Int. J. Antimicrob. Agents,2011

5. Establishing best practices and guidance in population modeling: an experience with an internal population pharmacokinetic analysis guidance;Byon;CPT Pharmacometrics Syst. Pharmacol.,2013

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Whole Body Physiologically Based Pharmacokinetic Model to Explain A Patient With Drug–Drug Interaction Between Voriconazole and Flucloxacillin;European Journal of Drug Metabolism and Pharmacokinetics;2024-09-14

2. Individualized regimen of Posaconazole oral suspension in Chinese HSCT patients based on population pharmacokinetic model;Scientific Reports;2024-08-31

3. Dosing of IV posaconazole to treat critically ill patients with invasive pulmonary aspergillosis: a population pharmacokinetics modelling and simulation study;Journal of Antimicrobial Chemotherapy;2024-06-03

4. Population Pharmacokinetic Modeling of Posaconazole in Japanese Patients Receiving Fungal Prophylaxis;Therapeutic Drug Monitoring;2024-04-04

5. Factors Influencing Serum Posaconazole Concentrations in Patients With Hematologic Malignancies Receiving Delayed-Release Tablets;Therapeutic Drug Monitoring;2024-04-04